This study presents a protocol for evaluating the effects of curcumin on retinoblastoma cell behavior through modulation of the Wnt/β-catenin pathway and miR-22 expression.
Research Article
* These authors contributed equally
This study presents a protocol for evaluating the effects of curcumin on retinoblastoma cell behavior through modulation of the Wnt/β-catenin pathway and miR-22 expression.
Retinoblastoma (RB) is a common intraocular malignant tumor affecting infants and children, yet its precise etiology and pathogenesis remain incompletely understood. Curcumin, a bioactive polyphenol, inhibits tumor progression via microRNA-mediated modulation of the Wnt/β-catenin signaling cascade. This study aimed to clarify how curcumin mediates its antitumor effects in RB by investigating its regulation of miRNA-22 (miR-22) expression and exploring the underlying molecular mechanisms. Two validated retinoblastoma models (SO-RB50/WERI-Rb-1) were treated with curcumin at varying concentrations. To delineate miR-22's regulation of Wnt/β-catenin signaling, target cells were transduced with either a miR-22 mimic lentivirus or a non-functional control lentivirus. Xenograft tumor models were established in mice using human RB cells to observe the in vivo effects of curcumin on tumor size, miR-22 expression, and Wnt/β-catenin protein levels. Cellular proliferation, invasion, and apoptosis were assessed using the CCK-8, Transwell, and Annexin V-APC-PI dual staining assay, respectively. miR-22 levels were quantified by RT-PCR, and Wnt1 and β-catenin expression profiles were determined by Western blot analysis. Curcumin treatment resulted in decreased proliferation and invasiveness in RB cells, while enhancing apoptosis and elevating miR-22 expression. Inhibition of miR-22 diminished curcumin's effects on the Wnt/β-catenin signaling pathway. In xenograft studies, curcumin significantly reduced tumor size and enhanced miR-22 expression within the tumors, effectively suppressing Wnt/β-catenin signaling. These findings demonstrate that curcumin inhibits RB cell proliferation and invasiveness while promoting apoptosis, primarily mediated through miR-22 upregulation and subsequent inhibition of the Wnt/β-catenin pathway.
Retinoblastoma (RB), a pediatric malignancy with high aggressiveness arising in retinal tissues, poses a substantial health threat, especially to children under the age of five. Genetic mutations, particularly those affecting the RB1 gene, are closely associated with the development of this disease1. Considering the significant prevalence of retinoblastoma (RB) among infants and children, coupled with the fact that approximately 9000 new cases are reported annually, predominantly in low-income and developing countries, a comprehensive understanding of the disease mechanisms is imperative for developing effective therapeutic strategies and impro....
Access restricted. Please log in or start a trial to view this content.
All procedures involving animals were reviewed and approved by the Animal Ethics and Welfare Committee (AEWC) of Tianjin Eye Hospital (Approval No. NKYY-DWLL-2023-054). The reagents and the equipment used are listed in the Table of Materials.
1. Cell culture
Cells of the human retinoblastoma lines WERI-Rb-1 and SO-RB50 were cultured in high-glucose Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. Cells were seeded at an appropriate density in culture flasks and maintained at 37 °C in a humidified atmosphere containing %CO
Access restricted. Please log in or start a trial to view this content.
Dose-Dependent anti-proliferative and anti-invasive effects of curcumin on human retinoblastoma cells, accompanied by Wnt/β-catenin pathway deactivation
Human RB cells were treated with varying curcumin doses over a 24 h period. The findings revealed a dose-dependent decline in cell viability and invasion, coupled with an increase in apoptosis. Specifically, as the concentration of curcumin increased from 10 to 50 µM, cell proliferation decreased progressively in both SO-Rb50 and WERI-Rb-1 cell lines.......
Access restricted. Please log in or start a trial to view this content.
Curcumin, a polyphenol derived from Curcuma longa rhizomes, is renowned for its anti-inflammatory, antiangiogenic, anti-proliferative, and antioxidant properties23,24. Additionally, it has antitumor properties, particularly its ability to induce apoptosis in malignant cells25. Although prior research has emphasized the growth-suppressive effects of curcumin on RB cells22,26,
Access restricted. Please log in or start a trial to view this content.
The authors have no conflicts of interest to declare.
National Natural Science Foundation of China (82271218); Tianjin Eye Hospital Science Fund (General Project ykyb1908).
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Annexin V-APC/PI dual staining kit | Solarbio | CA1020 | quantitatively assess apoptosis in RB cells via flow cytometry |
| CCK-8 Assay Kit | Beyotime | C0038 | measure the absorbance at 490 nm for evaluating cell proliferative capacity |
| CO2 incubator | Eppendorf | maintain optimal culture conditions (37°C, 5% CO2, and saturated humidity) for RB cell propagation | |
| Curcumin | Sigma | C1386 | Investigating the Anti-Tumor Effects of Curcumin on Retinoblastoma (RB) |
| ECL chemiluminescent substrate | Bioss | C05-07004 | visualize protein bands in Western blot analysis |
| Fetal Bovine Serum (FBS) | VivaCell | C04001-500 C04002-500 | Cell Culture |
| Flow cytometry | Beckman Coulter | Gallios | quantitatively analyze the apoptosis rate of cells |
| ImageJ Software | National Institutes of Health | version 6 | Western blot band analysis,assess protein expression levels |
| Inverted microscope | Olympus | CKX53 | observe and count invasive cells at 400× magnification in the Transwell assay |
| Lipofectamine 3000 | Invitrogen | L3000015 | Cell Transfection |
| Microplate reader | Thermo | K3 | enzyme-linked immunosorbent assay (ELISA) quantification |
| miR-22 mimic Lentivirus | Hanheng Biotechnology | hsa-miR-22 | establish a stably transfected cell line for animal experiments |
| Multiplex real-time PCR system | Bio-Rad | CFX384 | perform quantitative RT-PCR (qRT-PCR) for precise gene expression analysis |
| Penicillin-Streptomycin (PS) | Abbkine | BMC1030 | Added to cell culture media to prevent bacterial contamination |
| Protein Extraction Kit | Solarbio | BC3640-50T | protein isolation from cellular and tissue samples |
| psiCHECK-2 vector | promega | JR20110328 | construct Wnt1-WT (wild-type) and Wnt1-MUT (mutant) reporter plasmids for investigating the interaction between miR-22 and Wnt1 3'UTR |
| PVDF membrane | Merck | ISEQ00010 | protein blotting |
| Rabbit IgG secondary antibody | Cell Signaling Technologies | 14708 | Western blot detection by binding to the primary antibody |
| SPSS statistical software | IBM | SPSS 20.0 | perform statistical analysis on the experimental data |
| SuperScript III First-Strand Synthesis SuperMix Kit | Invitrogen | 11752-050 | reverse transcription of RNA into cDNA for subsequent RT-PCR analysis |
| SYBR Premix Ex Taq II Kit | TaKaRa Bio | RR820A | For RT-PCR to quantitatively detect the expression of Wnt1, β-actin, and other target genes |
| TRIzol reagent | Invitrogen | 12183-555 | RNA extraction from both cellular and tissue samples |
| UV spectrophotometer | Beckman | DU800 | determine the concentration and purity of RNA samples |
| Wnt1 antibody | Abcam | ab15251 | Western blot analysis to detect Wnt1 protein expression |
| β-actin antibody | Abcam | ab8227 | used as an internal reference to normalize protein loading in Western blot analysis |
| β-catenin antibody | Cell Signaling Technologies | 37447 | Western blot analysis to detect β-catenin protein expression |
Access restricted. Please log in or start a trial to view this content.
Request permission to reuse the text or figures of this JoVE article
Request Permission